19 Mar 2025Open access
Value of CODAC classification in identifying causes of stillbirthsPublisher siteArchives of Gynecology and Obstetrics, Maternal and Perinatal Health Interventions
UniversitiesHyem Khiari
Active, last published 2026
In global cancer incidence and screening
Hyem
Khiari
Scholar“Research focused on Global Cancer Incidence and Screening and adjacent fields.”
Institut Salah-Azaïz
Claim Your Profile5
H-index
47
Citations
Hyem has not officially claimed their profile. If you are Hyem, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
yem Khiari is a researcher working on Global Cancer Incidence and Screening. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Hyem's work has been cited 47 times across 2 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Global Cancer Incidence and Screening×9Cervical Cancer and HPV Research×4Breast Cancer Treatment Studies×4Multiple and Secondary Primary Cancers×3Reproductive tract infections research×2
04 · Where I am
Affiliations
Affiliation on published researchInstitut Salah-AzaïzDrawn from the institution listed on this researcher’s published work.
05 · Selected work
Recent publications
2 works1 Dec 2024Open access2cites
Cost-effectiveness of human papillomavirus (HPV) vaccination in Tunisia: a modelling studyPublisher siteBMJ Open, Cervical Cancer and HPV Research
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Hyem?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you